PDA Options: To view abstract content with the ability to bookmark to set up an itinerary that you can download and save to your PDA or computer, click on MY ITINERARY in the banner above; then proceed by searching the online database.



Sponsored by
Category Index Expand / Collapse All
Click on one of the following letters below to display a list of alphabetized categories.
Click the checkbox next to each item to bookmark.
A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
 A


Expand/Collapse Item Adjuvant Chemotherapy
Expand/Collapse Item Adjuvant Endocrine Therapy
Expand/Collapse Item Adjuvant Therapy - Other
Expand/Collapse Item Adjuvant Therapy - Targeted
Expand/Collapse Item Advanced Chemotherapy
Expand/Collapse Item Advanced Endocrine Therapy
Expand/Collapse Item Advanced Therapy - Targeted
Expand/Collapse Item Alternative Therapies
Expand/Collapse Item Angiogenesis
Expand/Collapse Item Animal Models
Expand/Collapse Item Antiangiogenic Therapy (Adjuvant and Metastatic)
Expand/Collapse Item Apoptosis and Senescence
Expand/Collapse Item Axillary Staging and Sentinel Nodes
  [23] Micrometastases and isolated tumor cells: relevant and robust or rubbish? (MIRROR): preliminary results of the MIRROR study from the Dutch breast cancer trialists' group (BOOG).
  [202] Sentinel node biopsy performed in the neoadjuvant setting for breast cancer: results from the I-SPY TRIAL (CALGB 150007/150012 & ACRIN 6657).
  [203] Validation and comparison of nomograms and scores to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph node: a prospective multicentric study.
  [204] The predictive probability of four different breast cancer nomograms for non-sentinel axillary lymph node metastasis in positive sentinel lymph node biopsy.
  [205] Prognostic implications of isolated tumour cells and micrometastasis in lymph nodes in non-adjuvant treated breast cancer patients.
  [206] Do isolated cells (pN0i+) in the sentinel lymph node change the post-operative management in breast cancer?
  [207] Sentinel lymph node biopsy in pure tubular carcinoma of the breast: a retrospective multicentric study of 234 cases.
  [1001] Allergic reactions to patent blue dye V – the ALMANAC and NEW START experience (on behalf of the ALMANAC study group).
  [1002] Quantitative intra-operative RT-PCR assay predicts size of sentinel node metastases.
  [1003] Intraoperative molecular sentinel lymph node analysis with OSNA: multicentre prospective UK evaluation.
  [1004] Intra-operative sentinel lymph node metastasis detection by “one-step nucleic acid amplification (OSNA)”: results of the french multicentric study.
  [1005] Assessment of the performance of the Stanford online calculator for the prediction of non-sentinel lymph node metastasis in sentinel node positive breast cancer patients.
  [1006] Technical aspects of the sentinel node biopsy in the EORTC AMAROS sentinel node trial.
  [1007] Value of axillary ultrasound and cytology in assessing nodal status preoperatively.
  [1008] Intra-operative touch imprint cytology for assessing sentinel lymph nodes in patients with lobular breast cancer.
  [1009] The significance of intramammary lymph node metastases in breast cancer management.
  [1010] Predicting the burden of axillary disease in breast cancer patients with a positive sentinel node.
  [1011] Optimal detection of micrometastases in sentinel lymph node of breast cancer: CBCSG-001 trial.
  [1012] Selective axillary node dissection differed from the arm lymph flow oriented by 3D-CT lymphography.
  [1013] Non-image guided fine needle aspiration of palpable axillary lymph nodes in breast cancer patients.
  [1014] Cost utility analysis on one-step nucleic acid amplification method for the detection of axillary metastasis in breast cancer.
  [1015] Prognostic significance of sentinel nodes metastases in breast cancer patients without axillary node dissection or axillary radiotherapy: CBCSG-001 trial.
  [1016] Intraoperative training on the techniques of sentinel node biopsy in breast cancer.
  [1017] Five year follow-up of patients with operable breast cancer whose sentinel nodes were completely sectioned at 0.25mm.
  [1018] The use of touch prep for the evaluation of sentinel lymph nodes in breast cancer.
  [1019] The use of ultrasound in pre-operative assessment of the axilla in breast cancer.
  [1020] Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
  [1021] A new hand-held gamma camera for sentinel node detection in breast cancer. The Minicam experience in 50 cases.
  [1022] Subareolar injection may not always identify the same sentinel lymph nodes as peritumoral injection in breast cancer.
  [1023] The value of preoperative axillary ultrasound staging in the management of early breast cancer.
  [1024] The anatomically correct incidence of internal mammary node drainage on lymphoscintigraphy.
  [1025] Correlation between pN0(mol+) and standard clinico-pathological prognostic factors in SLN of breast cancer patients.
  [1026] Sentinel lymph node detection in breast cancer patients by real-time virtual sonography constructed with three-dimensional computed tomography-lymphography.



 
 

Abstract Sessions | Support | FAQ | Privacy Policy

San Antonio Breast Cancer Symposium
7703 Floyd Curl Dr. Mail Code 8224
San Antonio, TX 78229 USA
http://www.sabcs.org
Technical Support • © 2010 Marathon Multimedia, a Learner’s Digest International business. • All rights reserved